Crisci Group adds another GMP manufacturing facility to its portfolio as Cann Pharma receives new TGA license.

A valuable exchange of ideas, industry insights and shared perspectives

Crisci Group leaders gain global insights at Fortuna One, inspiring new ideas for healthcare and future growth.

New Australian research has revealed encouraging findings on the role of medicinal cannabis in managing chronic conditions.

Our Head of Business and Product Development, Matthew Soliman, elected as a committee member of the ANZCCM.

Avril Vanin recognised as one of the best retail workers in South Australia.

We are walking 1 million steps on World Health Day for the Little Heroes Foundation and the fight against childhood dementia.

Introducing the new Cann Compounding logo, marking the brands evolution and commitment to future innovation.

Our new Releaf Dispensary located in Byron Bay is now open!

Reflecting on a successful year with the Crisci Group’s Queensland team.

Unveiling a new logo that reflects our purpose, values and future direction.

Cann Compounding joins IWG in becoming LegitScript certified.

A message from our CEO David Crisci.

Celebrating a year of growth, milestones and shared impact at the Crisci Group.

Crisci Group proudly sponsors the 2025 Little Heroes Melbourne Cup Luncheon

A night of teamwork, problem-solving and friendly competition with the Cann Compounding team.

Flora Holidings, the joint venture between the Crisci Group and Vitura Health acquires Ananda Clinic to expand patient care.

Our community joined forces for an unforgettable evening supporting the Little Heroes Foundation.

How we’re reinforcing our commitment to patient safety and care.

The team at our non-sterile compounding site explore their creative side at their annual team building event.